Neuralink
Company · Fremont, California, USA
Builds a fully implanted, wireless brain-computer interface with thousands of electrodes on flexible threads, placed by a custom surgical robot.
Neuralink’s N1 implant sits flush with the skull and records from about a thousand electrodes on ultra-thin polymer “threads” that a robot inserts into the motor cortex. Its first human participant was implanted in January 2024 under the PRIME feasibility study, controlling a computer cursor by thought.
The company has since expanded to multiple countries and trials, including studies on robotic-arm control, speech restoration and Blindsight, a visual-cortex stimulator intended to restore limited vision. In January 2026 Neuralink said 21 people had been implanted across its trials.
In the news
Neuralink shows a VOICE trial participant producing speech from brain signals
A participant with ALS used the N1 implant to generate synthesized speech in a voice rebuilt from earlier recordings. No peer-reviewed data has been published.
Neuralink reports 21 people implanted across its trials
The company's participant count has nearly doubled since September 2025, with studies spanning cursor control, robotic arms, speech and vision.
Neuralink hires the FDA's top neurological device regulator to lead medical affairs
David McMullen, who directed the FDA office overseeing neurological devices including BCIs, joins the company in late December.
First UK Neuralink patient controls a computer by thought hours after surgery
A man with motor neuron disease was implanted at University College London Hospitals as part of the GB-PRIME study.